Clinical Trial Update: Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial updates pembrolizumab with cisplatin-based chemotherapy as first-line treatment for advanced penile cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• cisplatin-based chemotherapy (cisplatin)

Snippet

Sponsor: Latin American Cooperative Oncology Group | Conditions: Penile Carcinoma | Phase 2 | Status: COMPLETED